Ergon Capital Partners SA is close to selling steroid-maker Zellbios in a transaction valuing the Luxembourg-based company at almost 200 million euros ($271 million), people familiar with the matter said. Ergon, based in Brussels, hired Jefferies Group LLC to manage the sale, the people said, asking not to be identified because the talks are private. Equistone Partners Europe is the frontrunner to buy Zellbios and a sale may be finalized within weeks, one of the people said.
Help employers find you! Check out all the jobs and post your resume.
